Multiple drug chemotherapy regimen for patients with hormonally-unresponsive carcinoma of the prostate: a preliminary report.

Journal Article

Of 25 patients with estrogen-unresponsive prostatic adenocarcinoma submitted to multi-drug chemotherapy 6 had partial objective regression, 12 had objectively stable disease and 7 had progressive disease. The survival rates in the 3 groups were 63, 52 and 40 weeks, respectively.

Full Text

Duke Authors

Cited Authors

  • Kane, RD; Stocks, LH; Paulson, DF

Published Date

  • April 1977

Published In

Volume / Issue

  • 117 / 4

Start / End Page

  • 467 - 471

PubMed ID

  • 850320

International Standard Serial Number (ISSN)

  • 0022-5347

Language

  • eng

Conference Location

  • United States